Intellipharmaceutics International Inc. (OTCMKTS:IPCIF) Sees Large Decline in Short Interest
Intellipharmaceutics International Inc. (OTCMKTS:IPCIF) Sees Large Decline in Short Interest
Receive News & Ratings for Intellipharmaceutics International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intellipharmaceutics International and related companies with MarketBeat.com's FREE daily email newsletter.Intellipharmaceutics International Inc. (OTCMKTS:IPCIF – Get Rating) (TSE:I) was the recipient of a significant drop in short interest in December. As of December 30th, there was short interest totalling 500 shares, a drop of 96.2% from the December 15th total of 13,200 shares. Based on an average daily volume of 30,800 shares, the days-to-cover ratio is currently 0.0 days.
Intellipharmaceutics International Inc.（OTCMKTS:IPCIF-获取评级）（TSE:I）在12月份空头持仓大幅下降。截至12月30日，空头持仓股数总计为500股，较12月15日的13,200股减少了96.2%。基于平均每日成交量为30,800股，目前的天数覆盖率为0.0天。
Intellipharmaceutics International Stock Performance
Intellipharmaceutics International股票表现
Shares of OTCMKTS IPCIF remained flat at $0.08 during midday trading on Thursday. The firm has a market capitalization of $2.54 million, a P/E ratio of -0.32 and a beta of 1.51. Intellipharmaceutics International has a one year low of $0.06 and a one year high of $0.16. The company's 50-day moving average is $0.08 and its 200-day moving average is $0.09.
OTCMKTS IPCIF的股票在周四午间交易中保持平稳，为0.08美元。公司市值为254万美元，市盈率为-0.32， beta为1.51。Intellipharmaceutics International一年内最低为0.06美元，最高为0.16美元。公司50日移动平均线为0.08美元，200日移动平均线为0.09美元。
About Intellipharmaceutics International
关于Intellipharmaceutics International
(Get Rating)
(获取评级)
Featured Articles
特色板块
- Get a free copy of the StockNews.com research report on Intellipharmaceutics International (IPCIF)
- Mid-Stream Operator Kinder Morgan: A High-Yield Value For 2023
- Why is T-mobile Down Despite Strong Preliminary Q4 Results?
- Procter & Gamble Earnings: A Gamble Worth Taking
- Stocks Slide, Economic Report Paints Gloomy Picture For Economy
- What does Nu Holdings Stock Have To Do With Warren Buffett?
- 免费获取StockNews.com对Intellipharmaceutics International（IPCIF）的研究报告
- 中游运营商Kinder Morgan：2023年的高收益价值股
- 为什么T-Mobile尽管强劲的Q4初步结果而下跌？
- 宝洁（Procter & Gamble）收益：值得冒险投资
- 股票下跌，经济报告为经济描绘出阴暗的前景
- Nu Holdings股票与Warren Buffett有什么关系？
Receive News & Ratings for Intellipharmaceutics International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intellipharmaceutics International and related companies with MarketBeat.com's FREE daily email newsletter.
获取Intellipharmaceutics International每日新闻和评级摘要-在下面输入您的电子邮件地址，即可获取MarketBeat.com的免费每日电子邮件新闻简报。